 Darren Gregory
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stevens-Johnson Syndrome | 10 | 2018 | 38 | 2.100 |
Why?
| | Dry Eye Syndromes | 11 | 2025 | 54 | 2.030 |
Why?
| | Amnion | 7 | 2017 | 28 | 1.490 |
Why?
| | Conjunctival Diseases | 7 | 2017 | 18 | 1.480 |
Why?
| | Corneal Diseases | 4 | 2018 | 34 | 0.710 |
Why?
| | Phacoemulsification | 2 | 2014 | 122 | 0.700 |
Why?
| | Glucocorticoids | 5 | 2024 | 596 | 0.640 |
Why?
| | Education, Medical, Graduate | 2 | 2014 | 481 | 0.570 |
Why?
| | Ophthalmology | 3 | 2015 | 86 | 0.520 |
Why?
| | Eyelid Diseases | 2 | 2016 | 19 | 0.480 |
Why?
| | Internship and Residency | 2 | 2014 | 1131 | 0.380 |
Why?
| | Teaching | 1 | 2014 | 226 | 0.360 |
Why?
| | Learning Curve | 1 | 2011 | 72 | 0.340 |
Why?
| | Acute Disease | 5 | 2016 | 1006 | 0.330 |
Why?
| | Clinical Competence | 2 | 2014 | 1093 | 0.270 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1799 | 0.270 |
Why?
| | Visual Acuity | 4 | 2016 | 348 | 0.250 |
Why?
| | Pemphigoid, Benign Mucous Membrane | 1 | 2024 | 6 | 0.230 |
Why?
| | Blindness, Cortical | 1 | 2003 | 5 | 0.220 |
Why?
| | Cataract Extraction | 1 | 2025 | 98 | 0.210 |
Why?
| | Masks | 1 | 2023 | 62 | 0.200 |
Why?
| | Ophthalmic Solutions | 2 | 2024 | 75 | 0.200 |
Why?
| | Lens Implantation, Intraocular | 2 | 2014 | 59 | 0.190 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 153 | 0.190 |
Why?
| | Pre-Eclampsia | 1 | 2003 | 189 | 0.180 |
Why?
| | Tobramycin | 2 | 2022 | 51 | 0.180 |
Why?
| | Epithelium, Corneal | 2 | 2018 | 41 | 0.170 |
Why?
| | Tears | 3 | 2025 | 28 | 0.170 |
Why?
| | Cyclosporine | 2 | 2022 | 268 | 0.160 |
Why?
| | Air Pollution | 1 | 2023 | 315 | 0.160 |
Why?
| | Cryopreservation | 2 | 2011 | 98 | 0.150 |
Why?
| | Serum | 1 | 2018 | 59 | 0.140 |
Why?
| | Humans | 27 | 2025 | 136783 | 0.140 |
Why?
| | Explosions | 1 | 2016 | 9 | 0.130 |
Why?
| | Fluorophotometry | 1 | 2016 | 3 | 0.130 |
Why?
| | Cicatrix | 1 | 2017 | 64 | 0.130 |
Why?
| | Eye Burns | 1 | 2016 | 12 | 0.130 |
Why?
| | Sclera | 1 | 2016 | 36 | 0.130 |
Why?
| | Conjunctivitis | 2 | 2024 | 30 | 0.130 |
Why?
| | Fluoroquinolones | 1 | 2016 | 50 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1235 | 0.120 |
Why?
| | Blast Injuries | 1 | 2016 | 48 | 0.120 |
Why?
| | Lacerations | 1 | 2016 | 35 | 0.120 |
Why?
| | Female | 16 | 2024 | 72840 | 0.120 |
Why?
| | Corneal Injuries | 1 | 2016 | 43 | 0.120 |
Why?
| | Hutchinson's Melanotic Freckle | 1 | 2015 | 3 | 0.120 |
Why?
| | Eyelid Neoplasms | 1 | 2015 | 10 | 0.120 |
Why?
| | Melanosis | 1 | 2015 | 16 | 0.120 |
Why?
| | Conjunctiva | 2 | 2023 | 51 | 0.120 |
Why?
| | Cryotherapy | 1 | 2015 | 17 | 0.110 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2016 | 109 | 0.110 |
Why?
| | Tissue Preservation | 2 | 2011 | 11 | 0.110 |
Why?
| | Guidelines as Topic | 1 | 2016 | 276 | 0.110 |
Why?
| | Lubricant Eye Drops | 2 | 2024 | 9 | 0.110 |
Why?
| | Dexamethasone | 1 | 2016 | 377 | 0.110 |
Why?
| | Meibomian Glands | 2 | 2024 | 18 | 0.100 |
Why?
| | Operative Time | 1 | 2014 | 146 | 0.100 |
Why?
| | Hospital Costs | 1 | 2014 | 119 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2025 | 2624 | 0.100 |
Why?
| | Operating Rooms | 1 | 2014 | 122 | 0.100 |
Why?
| | Orbital Diseases | 1 | 2012 | 32 | 0.090 |
Why?
| | Male | 12 | 2024 | 67361 | 0.090 |
Why?
| | Cataract | 2 | 2022 | 213 | 0.090 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 58 | 0.090 |
Why?
| | Prevalence | 3 | 2024 | 2712 | 0.090 |
Why?
| | Microsurgery | 1 | 2012 | 75 | 0.090 |
Why?
| | Brain | 1 | 2003 | 2669 | 0.090 |
Why?
| | Prospective Studies | 2 | 2016 | 7583 | 0.090 |
Why?
| | Disease Management | 1 | 2015 | 623 | 0.090 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 116 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2831 | 0.080 |
Why?
| | Child, Preschool | 5 | 2022 | 11069 | 0.080 |
Why?
| | Physician's Role | 1 | 2010 | 206 | 0.080 |
Why?
| | Aged | 4 | 2024 | 23729 | 0.070 |
Why?
| | Adipose Tissue | 1 | 2012 | 629 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1568 | 0.070 |
Why?
| | Chronic Disease | 1 | 2013 | 1784 | 0.070 |
Why?
| | Scleritis | 1 | 2007 | 23 | 0.070 |
Why?
| | Retinitis Pigmentosa | 1 | 2006 | 20 | 0.060 |
Why?
| | Adult | 6 | 2024 | 37616 | 0.060 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2006 | 25 | 0.060 |
Why?
| | Myopia | 1 | 2006 | 47 | 0.060 |
Why?
| | Quality of Life | 3 | 2025 | 2868 | 0.060 |
Why?
| | Surgical Flaps | 1 | 2007 | 130 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1683 | 0.060 |
Why?
| | Incidence | 2 | 2022 | 2788 | 0.060 |
Why?
| | Child | 5 | 2022 | 21968 | 0.060 |
Why?
| | Brazil | 1 | 2024 | 167 | 0.050 |
Why?
| | Adolescent | 4 | 2022 | 21463 | 0.050 |
Why?
| | Time Factors | 1 | 2014 | 6792 | 0.050 |
Why?
| | Loteprednol Etabonate | 1 | 2022 | 6 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2024 | 5115 | 0.050 |
Why?
| | Cornea | 1 | 2023 | 136 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2024 | 237 | 0.050 |
Why?
| | Retrospective Studies | 5 | 2024 | 15564 | 0.050 |
Why?
| | Middle Aged | 3 | 2024 | 33200 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 172 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2017 | 10764 | 0.040 |
Why?
| | Life Style | 1 | 2023 | 484 | 0.040 |
Why?
| | Particulate Matter | 1 | 2023 | 312 | 0.040 |
Why?
| | Suture Techniques | 2 | 2012 | 122 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 551 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 677 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7569 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2018 | 42 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1455 | 0.030 |
Why?
| | Facial Injuries | 1 | 2016 | 21 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 1107 | 0.030 |
Why?
| | Epidermis | 1 | 2016 | 157 | 0.030 |
Why?
| | Eye Diseases | 1 | 2016 | 87 | 0.030 |
Why?
| | Aminoquinolines | 1 | 2015 | 19 | 0.030 |
Why?
| | Necrosis | 1 | 2016 | 244 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2022 | 3537 | 0.030 |
Why?
| | Administration, Topical | 1 | 2015 | 148 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 13126 | 0.030 |
Why?
| | Infant | 2 | 2018 | 9442 | 0.030 |
Why?
| | Interferon-alpha | 1 | 2015 | 198 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2677 | 0.030 |
Why?
| | Prolapse | 1 | 2012 | 5 | 0.020 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2012 | 18 | 0.020 |
Why?
| | Tissue Adhesives | 1 | 2012 | 19 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 752 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1354 | 0.020 |
Why?
| | Skin | 1 | 2016 | 745 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5749 | 0.020 |
Why?
| | Biological Dressings | 1 | 2010 | 2 | 0.020 |
Why?
| | Pregnancy | 1 | 2003 | 6731 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5417 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2010 | 177 | 0.020 |
Why?
| | Wound Healing | 1 | 2009 | 323 | 0.020 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2006 | 30 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2006 | 32 | 0.020 |
Why?
| | United States | 1 | 2024 | 14660 | 0.020 |
Why?
| | Electroretinography | 1 | 2006 | 48 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 2006 | 35 | 0.020 |
Why?
| | Visual Fields | 1 | 2006 | 90 | 0.020 |
Why?
| | Fluorescein Angiography | 1 | 2006 | 150 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 2007 | 1164 | 0.010 |
Why?
|
|
Gregory's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|